Publication | Closed Access

Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis

Liver FibrosisPharmacotherapyNanomedicineMolecular PharmacologyTherapeutic NanomaterialsHepatotoxicityHedgehog InhibitorHepatology FibrosisRadiation OncologyNovel TherapyHealth SciencesFibrosisLiver PhysiologyPharmacologyHepatologyPpar-γ AgonistPharmaceutical NanotechnologyMedicineDrug Discovery